GI Insights

Host: Peter Buch, MD, FACG, AGAF, FACP

Guest: Chul Hyun, MD, PhD, MPH


Gastric cancer risk in the United States varies substantially across populations, yet prevention remains largely based on symptoms. Join Dr. Peter Buch and Dr. Chul Hyun, Director of the Gastric Cancer Prevention and Screening Program at the Yale School of Medicine, as they explore how recognizing key risk factors may help us identify patients who warrant closer evaluation.

Host: Peter Buch, MD, FACG, AGAF, FACP

Guest: David P. Hudesman, MD


Ulcerative colitis treatment continues to evolve with a growing range of targeted therapies, from S1P modulators to JAK inhibitors. Joining Dr. Peter Buch to discuss how clinicians can personalize care based on disease severity, safety profiles, and patient response is Dr. David Hudesman. He's a Professor in the Department of Medicine at NYU Grossman School of Medicine and the Director of NYU Langone’s Inflammatory Bowel Disease Center.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Sarah Cogle, PharmD, BCNSP, FASPEN


Evolving evidence supports the shift from single-source to multi-source intravenous lipid emulsions in parenteral nutrition. These newer formulations may offer improved metabolic, inflammatory, and hepatic outcomes, particularly for vulnerable patient populations. Joining Dr. Charles Turck to discuss the clinical rationale and operational considerations for these formulations is Dr. Sarah Cogle, who’s a Clinical Pharmacist Specialist at Vanderbilt University Medical Center in Nashville, Tennessee.

Host: Peter Buch, MD, FACG, AGAF, FACP

Guest: Aasma Shaukat, MD, MPH


Blood-based colorectal cancer screening is entering a new era with FDA-approved and emerging tests like Shield and Simple Screen. Alongside updated stool-based options such as Cologuard Plus and CRC-PREVENT, clinicians now have a broader landscape of noninvasive tools to consider and discuss with their patients. Joining Dr. Peter Buch to talk about current recommendations and potential future directions for colorectal cancer screening is Dr. Aasma Shaukat. Dr. Shaukat is the Robert M. and Mary H. Glickman Professor of Medicine and a Professor of Population Health at NYU Grossman School of Medicine, as well as the Director of Outcomes Research in the Division of Gastroenterology and Hepatology at NYU Langone Health. She's also a co-author of a recent review on blood tests for colorectal cancer.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Sarah Cogle, PharmD, BCNSP, FASPEN


Concerns over the inflammatory effects of traditional soybean-based lipid emulsions have prompted interest in alternatives like SMOFlipid—a four-oil blend designed to support hepatic function and reduce inflammation in parenteral nutrition. Joining Dr. Charles Turck to examine the clinical advantages, safety data, and key implementation strategies for SMOFlipid in adult patients is Dr. Sarah Cogle. Dr. Cogle is a Clinical Pharmacist Specialist at Vanderbilt University Medical Center in Nashville.